Why we are where we are....my $.02..
imo the fault totally lies with the actions of Murphy as CEO. KM is a brilliant man but he was proven as a total liability as a CEO. Missed revenue projections, missed yoy growth estimates, bad timing with dilution and lack of focus destroyed confidence in the ability of the company to maintain or increase sp. So he steps down and still receives $65,000 a month for his troubles. Money which the company sorely needs right now.
OK, now Crouch is on-board. In his first cc he noted that the first thing that he did was meet with the customers and listen to their needs. Makes me wonder if KM dictated to the potential customers their needs and did not listen to what they wanted? That can be off-putting. Also Crouch indicated that he sits in on at least 10 sales meetings a week. I believe that he is having to train an advanced degree sales staff with little or no sales experience. Just a hunch.
Looking at the track record of Crouch it is safe to say that he has been around the block a few times and he knows that there is no way in hell that he can miss any revenue projections going forward and he will probably "sand-bag" all of his projections. He has established focus on liver and kidney disease modeling, toxicity testing and therapeutic liver tissue.No more need to guess about what is going on. He has been working in this business for awhile and has been successful at it at other companies. I'm going to give him the benefit of a doubt and stay on board with ONVO for a while, but that's just my choice. Looking forward to the cc.
